uniQure N.V. | Key People and Executives
Matthew C. Kapusta
Director, Chief Executive & Financial Officer
David Schaffer
Non-Executive Director
Philip Astley-Sparke
Chairman
Jack L. Kaye
Independent Non-Executive Director
Madhavan Balachandran
Independent Non-Executive Director
Jeremy P. Springhorn
Independent Non-Executive Director
Paula Soteropoulos
Independent Non-Executive Director
Matthew C. Kapusta
Director, Chief Executive & Financial Officer
Scott T. McMillan
Chief Operating Officer
Robert Gut
Chief Medical Officer
Steven L. Zelenkofske
Chief Medical Officer
Sander J. van Deventer
Chief Scientific Officer
Jonathan Garen
Chief Business Officer
David Schaffer
Non-Executive Director
Christian Klemt
Chief Accounting Officer
Tom Malone
Director-Corporate Communications
Maria E. Cantor
Senior VP-Investor Relations & Communications
Eva M. Mulder
Investor & Media Relations Contact
Kathy Bodley
Senior Manager-Human Resources
David J. Cerveny
Secretary, Chief Legal Officer & General Counsel
Alexander Kuta
Senior Vice President-Regulatory Affairs
Philip Astley-Sparke
Chairman
Jack L. Kaye
Independent Non-Executive Director
Madhavan Balachandran
Independent Non-Executive Director
Jeremy P. Springhorn
Independent Non-Executive Director
Paula Soteropoulos
Independent Non-Executive Director
| Address |
Paasheuvelweg 25a
Amsterdam Noord-Holland 1105 BP
Netherlands
|
|
Employees
|
- |
| Website |
http://www.uniqure.com |
| Updated |
07/08/2019 |
| uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands. |
